Summary of H.R. 5999: Opioid Antagonist Prescription Waiver for Veterans
Overview
Bill Number: H.R. 5999
Title: To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription or copayment.
Status: Introduced in House
Introduced: November 10, 2025
Purpose and Intent
The primary goal of this bill is to improve access to opioid overdose reversal medication for veterans. Opioid overdose is a significant public health issue, and veterans are disproportionately affected due to high rates of chronic pain and mental health conditions. By removing barriers like prescriptions and copayments, the bill aims to equip more veterans with the life-saving tools they need to prevent fatal overdoses.
Key Provisions
- Requires the Secretary of Veterans Affairs to provide opioid antagonists (e.g. naloxone) to any veteran without requiring a prescription
- Prohibits the VA from charging veterans a copayment or other cost-sharing for opioid antagonists
- Directs the VA to establish educational programs to train veterans and their families on the proper use of opioid antagonists
Affected Parties and Impacts
- Veterans would be the primary beneficiaries, gaining easier access to opioid overdose reversal medication at no personal cost
- The VA healthcare system would be responsible for procuring, distributing, and educating veterans on the use of opioid antagonists
- Broader public health benefits could be realized if the legislation helps reduce opioid overdose deaths among the veteran population
Procedural and Timeline Considerations
H.R. 5999 was introduced in the House of Representatives on November 10, 2025 and has been referred to the House Committee on Veterans' Affairs for consideration. If passed by the House, the bill would then move to the Senate for further review and potential amendments before a final vote. Given the bipartisan support for improving veteran healthcare access, the bill has a reasonable chance of advancing through the legislative process, though the timeline for enactment remains uncertain.
